This is a Validated Antibody Database (VAD) review about human PLA2G4A, based on 18 published articles (read how Labome selects the articles), using PLA2G4A antibody in all methods. It is aimed to help Labome visitors find the most suited PLA2G4A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PLA2G4A synonym: PLA2G4; cPLA2; cPLA2-alpha; cytosolic phospholipase A2; calcium-dependent phospholipid-binding protein; lysophospholipase; phosphatidylcholine 2-acylhydrolase; phospholipase A2, group IVA (cytosolic, calcium-dependent)
Santa Cruz Biotechnology
mouse monoclonal (4-4B-3C) |
| Santa Cruz Biotechnology PLA2G4A antibody (SantaCruz, sc-454) was used in western blot on mouse samples at 1:500-1:1000 (fig 3). Biol Pharm Bull (2018) ncbi |
mouse monoclonal (4-4B-3C) |
| Santa Cruz Biotechnology PLA2G4A antibody (Santa Cruz, sc454) was used in immunohistochemistry on human samples (fig 5k) and in western blot on human samples (fig 2a-c,3a). Sci Rep (2017) ncbi |
mouse monoclonal (4-4B-3C) |
| Santa Cruz Biotechnology PLA2G4A antibody (Santa Cruz, sc-454) was used in western blot on human samples at 1:1000 (fig 1a). Front Pharmacol (2016) ncbi |
mouse monoclonal (4-4B-3C) |
| Santa Cruz Biotechnology PLA2G4A antibody (SantaCruz, sc-454) was used in western blot on human samples at 1:500 (fig 4a). Endocrinology (2016) ncbi |
mouse monoclonal (4-4B-3C) |
| In order to determine how cytosolic phospholipase A2alpha prohibits prostate cancer cells from re-entering the cell cyle, Santa Cruz Biotechnology PLA2G4A antibody (Santa Cruz Biotechnology, sc-454) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi |
mouse monoclonal (4-4B-3C) |
| Santa Cruz Biotechnology PLA2G4A antibody (Santa Cruz Biotechnology, sc-454) was used in western blot on human samples at 1:1000. Biochim Biophys Acta (2015) ncbi |
mouse monoclonal (4-4B-3C) |
| In order to analyze how the inhibition constitutively activates protein kinase B (AKT) and cell proliferation caused by targeting cytosolic phospholipase A2 alpha in colorectal cancer cells, Santa Cruz Biotechnology PLA2G4A antibody (Santa Cruz, SC-454) was used in western blot on human samples (fig 1). Oncotarget (2014) ncbi |
mouse monoclonal (4-4B-3C) |
| Santa Cruz Biotechnology PLA2G4A antibody (Santa Cruz, sc-454) was used in western blot on rat samples . PLoS ONE (2014) ncbi |
mouse monoclonal (4-4B-3C) |
| In order to describe a fast semi-quantitative colony immunoassay to detect intracellularly expressed proteins in both yeast and bacterial cells, Santa Cruz Biotechnology PLA2G4A antibody (Santa Cruz Biotechnology, sc-454) was used in western blot on scFv samples at 1:1000 (fig 2). Anal Biochem (2014) ncbi |
mouse monoclonal (4-4B-3C) |
| Santa Cruz Biotechnology PLA2G4A antibody (Santa Cruz Biotechnology, SC-454) was used in western blot on human samples (fig 4). Magn Reson Med (2014) ncbi |
Invitrogen
rabbit polyclonal |
| In order to use cell lipid fingerprinting to predict the physiological and pathological status of a cell, Invitrogen PLA2G4A antibody (Thermo Scientific, PA5-29100) was used in immunohistochemistry on human samples at 1:1500 (fig 3e). Biochim Biophys Acta (2016) ncbi |
Abcam
rabbit polyclonal |
| In order to perform lipidomic profiling of MYC-dependent lung tumors, Abcam PLA2G4A antibody (Abcam, ab53105) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5a). Cancer Res (2016) ncbi |
GeneTex
rabbit polyclonal |
| In order to investigate a prostaglandin E2 biosynthetic system in the Golgi apparatus, GeneTex PLA2G4A antibody (Genetex, GTX117583) was used in western blot on human samples . J Biol Chem (2015) ncbi |
Cell Signaling Technology
rabbit polyclonal |
| Cell Signaling Technology PLA2G4A antibody (Cell Signal, 2831) was used in western blot on pig samples (fig 5b). Oncotarget (2017) ncbi |
rabbit polyclonal |
| Cell Signaling Technology PLA2G4A antibody (Cell Signaling, 2831) was used in western blot on mouse samples at 1:1000 (fig 6D). FASEB J (2017) ncbi |
rabbit polyclonal |
| Cell Signaling Technology PLA2G4A antibody (Cell signaling, 2831) was used in western blot on mouse samples at 1:1000 (fig s7c). Nat Commun (2016) ncbi |
rabbit polyclonal |
| Cell Signaling Technology PLA2G4A antibody (Cell signaling, 2832) was used in western blot on mouse samples at 1:1000 (fig s7c). Nat Commun (2016) ncbi |
rabbit polyclonal |
| Cell Signaling Technology PLA2G4A antibody (Cell Signaling, 2832) was used in western blot on mouse samples at 1:1000 (fig 6). Nat Commun (2016) ncbi |
rabbit polyclonal |
| Cell Signaling Technology PLA2G4A antibody (Cell Signaling, 2831) was used in western blot on mouse samples at 1:1000 (fig 6). Nat Commun (2016) ncbi |
rabbit polyclonal |
| Cell Signaling Technology PLA2G4A antibody (Cell Signalling Technology, 2831) was used in western blot on human samples at 1:1000. Biochim Biophys Acta (2015) ncbi |
Sigma-Aldrich
rabbit polyclonal |
| Sigma-Aldrich PLA2G4A antibody (sigma, SAB4503812) was used in immunohistochemistry on human samples (fig 5k) and in western blot on human samples (fig 2a-c,3a). Sci Rep (2017) ncbi |
rabbit polyclonal |
| In order to determine the role and diagnostic efficacy of RB1, CDK4, CHMP2B, HSP90, and cPLA2G4A as markers in myxofibrosarcomas and myxoid liposarcomas, Sigma-Aldrich PLA2G4A antibody (Sigma, SAB4502200) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Int J Surg Pathol (2014) ncbi |
Articles Reviewed
- Lin C, Lin W, Cho R, Wang C, Hsiao L, Yang C. TNF-?-Induced cPLA2 Expression via NADPH Oxidase/Reactive Oxygen Species-Dependent NF-?B Cascade on Human Pulmonary Alveolar Epithelial Cells. Front Pharmacol. 2016;7:447 pubmed
- Liu C, Guo C, Wang W, Zhu P, Li W, Mi Y, et al. Inhibition of Lysyl Oxidase by Cortisol Regeneration in Human Amnion: Implications for Rupture of Fetal Membranes. Endocrinology. 2016;157:4055-4065 pubmed
- Zheng Z, He X, Xie C, Hua S, Li J, Wang T, et al. Targeting cytosolic phospholipase A2 α in colorectal cancer cells inhibits constitutively activated protein kinase B (AKT) and cell proliferation. Oncotarget. 2014;5:12304-16 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments